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W
e thank Vendrame and Dotta (1) for their in-
teresting perspective regarding our recently
published study investigating the role of
interleukin-16 (IL-16) in the development of
insulitis and type 1 diabetes in female NOD mice (2). On
the basis of previous studies correlating suboptimal acti-
vation of caspase-3 with the development of autoimmunity
in the clinical setting (3,4), they propose a similar condi-
tion might exist in NOD mice, resulting in defective se-
cretion of mature IL-16. Although we have not directly
examined this possibility, it must be considered that many
studies have wrestled with the difﬁculty in detecting secreted
IL-16 in several mouse strains used to examine inﬂammatory
responses (2,5). This likely reﬂects the biology of mature
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and indicates that the low levels of intrapancreatic mature
IL-16 detected during the development of insulitis is not re-
stricted only to the NOD genetic background.
However, the notion that caspase-3 activation may be
suboptimal in NOD mice is suggested by several articles
reporting that T cells in NOD mice exhibit an altered sig-
naling cascade downstream of the T-cell receptor, result-
ing in a hyporesponsive state of activation and resistance
to activation-induced cell death (6–8). Importantly, al-
though it may be that a reduction in caspase-3 activation
leads to diminished IL-16 secretion, this correlation has
not yet been proven and the level of activated caspase-3
required for cleavage of pro–IL-16 is unknown. Thus, in
support of the perspective by Vendrame and Dotta, it is
uncertain how a partial deﬁciency in caspase-3 activation
would affect levels of IL-16 secretion; but clearly, based
on our results, the level of caspase-3 activation occurring
in lymphocytes is sufﬁcient for the secretion of IL-16
and recruitment of T cells needed for disease pathology.
Collectively, a partial deﬁciency in caspase-3 activation
may contribute to T-cell resistance to activation-induced
cell death, which would enable autoreactive T cells to
persist and may also facilitate their recruitment to islets
via secretion of mature IL-16.
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